Inhibitor Therapeutics (INTI) Return on Assets [ROA] (2013 - 2026)
Inhibitor Therapeutics (INTI) reported Return on Assets [ROA] of -319.52% for Q2 2026, down 237.61 percentage points from -81.91% a year earlier and down 149.47 percentage points from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Return on Assets [ROA] (2013 - 2026) Analysis & Trends
For FY2025, Inhibitor Therapeutics posted Return on Assets [ROA] of -80.44%, down 34.83 percentage points from FY2024.
- Return on Assets [ROA] has declined for three consecutive years, though with a five-year change of +124.85 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -45.61% in FY2024 (-16.68 pp), -28.92% in FY2023 (-230.13 pp), 201.20% in FY2022 (+514.66 pp) and -313.45% in FY2021 (-108.17 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q3 2022.
- Year over year, Return on Assets [ROA] has now declined in each of the last 11 quarters, with an average year-over-year change of -71.23 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q3 2021 (a gain of 717.60 percentage points); the low point was Q3 2022 (a drop of 249.07 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -170.05% (Q1 2026), -116.90% (Q4 2025) and -97.31% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | -319.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -319.52% |
| Mar 31, 2026 | -170.05% |
| Dec 31, 2025 | -116.90% |
| Sep 30, 2025 | -97.31% |
| Jun 30, 2025 | -81.91% |
| Mar 31, 2025 | -64.46% |
| Dec 31, 2024 | -54.98% |
| Sep 30, 2024 | -45.28% |
| Jun 30, 2024 | -40.33% |
| Mar 31, 2024 | -37.88% |
| Dec 31, 2023 | -32.61% |
| Sep 30, 2023 | -23.13% |
| Jun 30, 2023 | -16.18% |
| Mar 31, 2023 | -9.84% |
| Dec 31, 2022 | -11.32% |
| Sep 30, 2022 | -556.76% |
| Jun 30, 2022 | -544.82% |
| Mar 31, 2022 | -427.85% |
| Dec 31, 2021 | -430.13% |
| Sep 30, 2021 | -307.69% |
API Access
Inhibitor Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();